Dr Tanna received his medical degree at the Columbia University College of Physicians and Surgeons. He completed his ophthalmology residency and glaucoma fellowship at the Wilmer Eye Institute of The Johns Hopkins University School of Medicine.

Dr Tanna’s research focuses on the efficacy and safety of glaucoma medications, techniques to modulate wound healing after incisional glaucoma surgery, methods to confirm the stability of the glaucoma disease process over time, abnormalities in ocular blood flow in different types of glaucoma, and the assessment of visual function in glaucoma. Dr Tanna has been a principal investigator (PI) in several clinical trials and currently serves as one of the PIs of the NEI COAST clinical trial. His recent studies in collaboration with biomedical engineers centre around the use of hydrogel polymers to prevent excessive fibrosis after trabeculectomy.

Dr Tanna received the American Academy of Ophthalmology Senior Achievement Award in 2017, the Secretariat Award in 2019 and has received several teaching awards at Northwestern. He has served in various leadership roles in the American Glaucoma Society and also as a member of its board of directors. He previously chaired the American Academy of Ophthalmology’s Basic and Clinical Science Course Glaucoma Committee. Dr Tanna is co-editor of the 3rd edition of Glaucoma Medical Therapy and serves on the editorial boards of four peer-reviewed journals: Ophthalmology, Survey of Ophthalmology, Scientific Reports and Ophthalmology Glaucoma.

Dr Bovee is a leader in organized medicine, an advocate for her patients, an innovator in the pharmaceutical and medical device industry and enjoys teaching cutting-edge ophthalmology techniques.

Dr Bovee was named the 2020 Florida Society of Ophthalmology Outstanding Young Ophthalmologist and awarded the Michael R Redmond Ophthalmology Leadership Award. She has also received the prestigious ‘Excellence in Medicine Award’ from the American Medical Association.

Dr Panarelli received his BS in Finance from Georgetown University’s McDonough School of Business in 2003 and his medical degree from the Georgetown University School of Medicine in 2007, where he was elected to the Alpha Omega Alpha honour medical society during his junior year. He completed a residency in ophthalmology at the New York Eye and Ear Infirmary, where he served as chief resident during his final year of training. He was awarded the William and Judith Turner Award for excellence in ophthalmologic training. Following a year of fellowship training in glaucoma at the Bascom Palmer Eye Institute in Miami, he joined the faculty at Bascom Palmer for an additional year, prior to returning to New York Eye and Ear as a member of the full-time faculty. For 5 years at the New York Eye and Ear Infirmary, he was active in resident education, serving as the associate residency program director as well as glaucoma fellowship director. Dr Panarelli transitioned to NYU where he serves as the director in the Division of Glaucoma Services.

Dr Panarelli is certified by the American Board of Ophthalmology, and he is a member of the American Glaucoma Society as well as the American Academy of Ophthalmology. He is the recipient of several awards, including the Mentoring for Advancement of Physician-Scientist Award from the American Glaucoma Society, and was selected as a Castle Connolly Top Doctor from 2017–2023.

He has published extensively in his field and is a principal investigator for numerous studies pertaining to the surgical management of glaucoma.